Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Sarah Power

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Intensive Care Medicine|July 24, 2015
Regional variation in critical care provision and outcome after high-risk surgeryMichael A Gillies, G Sarah Power, David A Harrison, et al.
Obesity (Silver Spring, Md.)|May 8, 2019
Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in CanadaSean Wharton, Aiden Liu, Arash Pakseresht, et al.
Obesity Science & Practice|September 3, 2020
Weight loss and persistence with liraglutide 3.0 mg by obesity class in the real-world effectiveness study in CanadaSean Wharton, Christiane L Haase, Elham Kamran, et al.
Obesity (Silver Spring, Md.)|September 24, 2019
Response to "Liraglutide Effectiveness: Is There a Real-World Clinical Benefit?"Sean Wharton, Aiden Liu, Arash Pakseresht, et al.
Headache|April 11, 2022
A real-world, observational study of erenumab for migraine prevention in Canadian patientsWerner J Becker, Sian Spacey, Elizabeth Leroux, et al.
The New England Journal of Medicine|March 18, 2015
Trial of early, goal-directed resuscitation for septic shockPaul R Mouncey, Tiffany M Osborn, G Sarah Power, et al.
Health Technology Assessment (Winchester, England)|November 25, 2015
Protocolised Management In Sepsis (ProMISe): a multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shockPaul R Mouncey, Tiffany M Osborn, G Sarah Power, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Intensive Care Medicine|July 24, 2015
Regional variation in critical care provision and outcome after high-risk surgeryMichael A Gillies, G Sarah Power, David A Harrison, et al.
Obesity (Silver Spring, Md.)|May 8, 2019
Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in CanadaSean Wharton, Aiden Liu, Arash Pakseresht, et al.
Obesity Science & Practice|September 3, 2020
Weight loss and persistence with liraglutide 3.0 mg by obesity class in the real-world effectiveness study in CanadaSean Wharton, Christiane L Haase, Elham Kamran, et al.
Obesity (Silver Spring, Md.)|September 24, 2019
Response to "Liraglutide Effectiveness: Is There a Real-World Clinical Benefit?"Sean Wharton, Aiden Liu, Arash Pakseresht, et al.
Headache|April 11, 2022
A real-world, observational study of erenumab for migraine prevention in Canadian patientsWerner J Becker, Sian Spacey, Elizabeth Leroux, et al.
The New England Journal of Medicine|March 18, 2015
Trial of early, goal-directed resuscitation for septic shockPaul R Mouncey, Tiffany M Osborn, G Sarah Power, et al.
Health Technology Assessment (Winchester, England)|November 25, 2015
Protocolised Management In Sepsis (ProMISe): a multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shockPaul R Mouncey, Tiffany M Osborn, G Sarah Power, et al.
Pageof 2